Clinical Trials Logo

Clinical Trial Summary

To explore the effect of letermovir prophylaxis on cytomegalovirus-specific immune reconstitution post unrelated cord blood transplantation


Clinical Trial Description

To explore the effect of letermovir prophylaxis on cytomegalovirus-specific and other lymphocyte subsets immune reconstitution post unrelated cord blood transplantation, and to analyze the potential mechanism and risk factors of late CMV reactivation after letermovir discontinuation. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06441669
Study type Observational
Source Anhui Provincial Hospital
Contact Xiaoyu Zhu, ph.D
Phone 15255456091
Email xiaoyuz@ustc.edu.cn
Status Recruiting
Phase
Start date May 1, 2024
Completion date May 20, 2026

See also
  Status Clinical Trial Phase
Completed NCT02645396 - A Cohort Study of Congenital Cytomegalovirus Infection Among Pregnant Women and Their Newborns in China